Ryzodeg

insulin degludec/insulin aspart · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Ryzodeg, covering 2015-11-17 to 2025-03-04. Get the full timeline:

Most recent: EMA Authorised: Ryzodeg (insulin aspart;insulin degludec) — Novo Nordisk A/S